These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 28762651)

  • 1. Provision of pharmaceutical care by community pharmacists across Europe: Is it developing and spreading?
    Costa FA; Scullin C; Al-Taani G; Hawwa AF; Anderson C; Bezverhni Z; Binakaj Z; Cordina M; Foulon V; Garcia de Bikuña B; de Gier H; Granås AG; Grinstova O; Griese-Mammen N; Grincevicius J; Grinceviciene S; Kaae S; Kubiliene L; Mariño EL; Martins S; Modamio P; Nadin G; Nørgaard LS; Obarcanin E; Tadic I; Tasic L; McElnay JC; Hersberger KE; Westerlund T
    J Eval Clin Pract; 2017 Dec; 23(6):1336-1347. PubMed ID: 28762651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of pharmaceutical care by community pharmacists: a comparison across Europe.
    Hughes CM; Hawwa AF; Scullin C; Anderson C; Bernsten CB; Björnsdóttir I; Cordina MA; da Costa FA; De Wulf I; Eichenberger P; Foulon V; Henman MC; Hersberger KE; Schaefer MA; Søndergaard B; Tully MP; Westerlund T; McElnay JC
    Pharm World Sci; 2010 Aug; 32(4):472-87. PubMed ID: 20458539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacy practice in China: past, present and future.
    Fang Y; Yang S; Zhou S; Jiang M; Liu J
    Int J Clin Pharm; 2013 Aug; 35(4):520-8. PubMed ID: 23661172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services throughout Europe.
    Soares IB; Imfeld-Isenegger TL; Makovec UN; Horvat N; Kos M; Arnet I; Hersberger KE; Costa FA
    Res Social Adm Pharm; 2020 Jan; 16(1):41-47. PubMed ID: 30737196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competence, competition and collaboration: Perceived challenges among Swedish community pharmacists engaging in pharmaceutical services provision and research.
    Frisk P; Holtendal C; Bastholm-Rahmner P; Sporrong SK
    Int J Pharm Pract; 2019 Aug; 27(4):346-354. PubMed ID: 30707481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The organizational framework of community pharmacies in Europe.
    Martins SF; van Mil JW; da Costa FA
    Int J Clin Pharm; 2015 Oct; 37(5):896-905. PubMed ID: 26017399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers?
    Aburuz S; Al-Ghazawi M; Snyder A
    Int J Pharm Pract; 2012 Apr; 20(2):71-9. PubMed ID: 22416931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
    Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
    Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Perceptions and Improvement Approaches of Pharmaceutical Care Capacity of Community Pharmacists: A Quantitative Analysis Based on Survey Data at Chinese Chain Pharmacies.
    Tang Z; Lhamu P; Ye H; Hong L; Xiang X
    Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33066654
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
    Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
    Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community and hospital pharmacists in Europe: encroaching on medicine?
    Garattini L; Padula A; Mannucci PM
    Intern Emerg Med; 2021 Jan; 16(1):7-10. PubMed ID: 32920655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacists' perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China.
    Fang Y; Yang S; Feng B; Ni Y; Zhang K
    Health Soc Care Community; 2011 Mar; 19(2):189-97. PubMed ID: 20880089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacist-led medication review procedures across Europe: Characterization, implementation and remuneration.
    Imfeld-Isenegger TL; Soares IB; Makovec UN; Horvat N; Kos M; van Mil F; Costa FA; Hersberger KE
    Res Social Adm Pharm; 2020 Aug; 16(8):1057-1066. PubMed ID: 31734100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross-sectional survey of enhanced and extended professional services in community pharmacies: A pharmacy perspective.
    Sim TF; Wright B; Hattingh L; Parsons R; Sunderland B; Czarniak P
    Res Social Adm Pharm; 2020 Apr; 16(4):511-521. PubMed ID: 31300355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.